162 related articles for article (PubMed ID: 21490684)
1. The influence of epileptic neuropathology and prior peripheral immunity on CNS transduction by rAAV2 and rAAV5.
Weinberg MS; Blake BL; Samulski RJ; McCown TJ
Gene Ther; 2011 Oct; 18(10):961-8. PubMed ID: 21490684
[TBL] [Abstract][Full Text] [Related]
2. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system.
Burger C; Gorbatyuk OS; Velardo MJ; Peden CS; Williams P; Zolotukhin S; Reier PJ; Mandel RJ; Muzyczka N
Mol Ther; 2004 Aug; 10(2):302-17. PubMed ID: 15294177
[TBL] [Abstract][Full Text] [Related]
3. Circulating anti-wild-type adeno-associated virus type 2 (AAV2) antibodies inhibit recombinant AAV2 (rAAV2)-mediated, but not rAAV5-mediated, gene transfer in the brain.
Peden CS; Burger C; Muzyczka N; Mandel RJ
J Virol; 2004 Jun; 78(12):6344-59. PubMed ID: 15163728
[TBL] [Abstract][Full Text] [Related]
4. Anticonvulsant effects and behavioural outcomes of rAAV serotype 1 vector-mediated neuropeptide Y overexpression in rat hippocampus.
Noe F; Vaghi V; Balducci C; Fitzsimons H; Bland R; Zardoni D; Sperk G; Carli M; During MJ; Vezzani A
Gene Ther; 2010 May; 17(5):643-52. PubMed ID: 20220782
[TBL] [Abstract][Full Text] [Related]
5. Pre-existing immunity to adeno-associated virus (AAV)2 limits transgene expression following intracerebral AAV2-based gene delivery in a 6-hydroxydopamine model of Parkinson's disease.
Janelidze S; Nordström U; Kügler S; Brundin P
J Gene Med; 2014; 16(9-10):300-8. PubMed ID: 25303717
[TBL] [Abstract][Full Text] [Related]
6. Astrocyte-selective AAV gene therapy through the endogenous GFAP promoter results in robust transduction in the rat spinal cord following injury.
Griffin JM; Fackelmeier B; Fong DM; Mouravlev A; Young D; O'Carroll SJ
Gene Ther; 2019 May; 26(5):198-210. PubMed ID: 30962538
[TBL] [Abstract][Full Text] [Related]
7. Cellular selectivity of AAV serotypes for gene delivery in neurons and astrocytes by neonatal intracerebroventricular injection.
Hammond SL; Leek AN; Richman EH; Tjalkens RB
PLoS One; 2017; 12(12):e0188830. PubMed ID: 29244806
[TBL] [Abstract][Full Text] [Related]
8. Adeno-associated virus (AAV) serotypes 2, 4 and 5 display similar transduction profiles and penetrate solid tumor tissue in models of human glioma.
Thorsen F; Afione S; Huszthy PC; Tysnes BB; Svendsen A; Bjerkvig R; Kotin RM; Lønning PE; Hoover F
J Gene Med; 2006 Sep; 8(9):1131-40. PubMed ID: 16810631
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the transduction efficiency of tyrosine-mutant adeno-associated virus serotype vectors in kidney.
Qi YF; Li QH; Shenoy V; Zingler M; Jun JY; Verma A; Katovich MJ; Raizada MK
Clin Exp Pharmacol Physiol; 2013 Jan; 40(1):53-5. PubMed ID: 23216315
[TBL] [Abstract][Full Text] [Related]
10. Adeno-associated virus-mediated expression and constitutive secretion of galanin suppresses limbic seizure activity in vivo.
McCown TJ
Mol Ther; 2006 Jul; 14(1):63-8. PubMed ID: 16730475
[TBL] [Abstract][Full Text] [Related]
11. Adeno-associated viral serotypes differentially transduce inhibitory neurons within the rat amygdala.
de Solis CA; Hosek MP; Holehonnur R; Ho A; Banerjee A; Luong JA; Jones LE; Chaturvedi D; Ploski JE
Brain Res; 2017 Oct; 1672():148-162. PubMed ID: 28764932
[TBL] [Abstract][Full Text] [Related]
12. Human blue-opsin promoter preferentially targets reporter gene expression to rat s-cone photoreceptors.
Glushakova LG; Timmers AM; Pang J; Teusner JT; Hauswirth WW
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3505-13. PubMed ID: 16877422
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptide Y gene therapy decreases chronic spontaneous seizures in a rat model of temporal lobe epilepsy.
Noè F; Pool AH; Nissinen J; Gobbi M; Bland R; Rizzi M; Balducci C; Ferraguti F; Sperk G; During MJ; Pitkänen A; Vezzani A
Brain; 2008 Jun; 131(Pt 6):1506-15. PubMed ID: 18477594
[TBL] [Abstract][Full Text] [Related]
14. Adeno-associated virus vector-mediated expression and constitutive secretion of galanin suppresses limbic seizure activity.
McCown TJ
Neurotherapeutics; 2009 Apr; 6(2):307-11. PubMed ID: 19332324
[TBL] [Abstract][Full Text] [Related]
15. Adeno-associated virus-mediated expression and constitutive secretion of NPY or NPY13-36 suppresses seizure activity in vivo.
Foti S; Haberman RP; Samulski RJ; McCown TJ
Gene Ther; 2007 Nov; 14(21):1534-6. PubMed ID: 17713567
[TBL] [Abstract][Full Text] [Related]
16. Transduction efficiency of neurons and glial cells by AAV-1, -5, -9, -rh10 and -hu11 serotypes in rat spinal cord following contusion injury.
Petrosyan HA; Alessi V; Singh V; Hunanyan AS; Levine JM; Arvanian VL
Gene Ther; 2014 Dec; 21(12):991-1000. PubMed ID: 25119378
[TBL] [Abstract][Full Text] [Related]
17. Directed evolution of a novel adeno-associated virus (AAV) vector that crosses the seizure-compromised blood-brain barrier (BBB).
Gray SJ; Blake BL; Criswell HE; Nicolson SC; Samulski RJ; McCown TJ; Li W
Mol Ther; 2010 Mar; 18(3):570-8. PubMed ID: 20040913
[TBL] [Abstract][Full Text] [Related]
18. Adenosine kinase, glutamine synthetase and EAAT2 as gene therapy targets for temporal lobe epilepsy.
Young D; Fong DM; Lawlor PA; Wu A; Mouravlev A; McRae M; Glass M; Dragunow M; During MJ
Gene Ther; 2014 Dec; 21(12):1029-40. PubMed ID: 25231174
[TBL] [Abstract][Full Text] [Related]
19. Adeno-associated viral vector serotypes 1 and 5 targeted to the neonatal rat and pig striatum induce widespread transgene expression in the forebrain.
Kornum BR; Stott SR; Mattsson B; Wisman L; Ettrup A; Hermening S; Knudsen GM; Kirik D
Exp Neurol; 2010 Mar; 222(1):70-85. PubMed ID: 20025873
[TBL] [Abstract][Full Text] [Related]
20. Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates.
Gray SJ; Nagabhushan Kalburgi S; McCown TJ; Jude Samulski R
Gene Ther; 2013 Apr; 20(4):450-9. PubMed ID: 23303281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
